key: cord-1010679-p4eujyxm
authors: Dhar, Shrinjana; Bhattacharjee, Pritha
title: Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation
date: 2021-04-20
journal: J Funct Foods
DOI: 10.1016/j.jff.2021.104503
sha: ce43a41cb686cab8067c225c16ac000c6ec9b4f5
doc_id: 1010679
cord_uid: p4eujyxm

Curcumin has already acknowledged immense interest from both medical and scientific research because of its multifaceted activity. To date, the promising effects of curcumin were perceived against numerous inflammatory diseases. Besides, curcumin’s role as a medicine has been studied in many virus infections like influenza, HIV, etc. There is a need to analyze the cellular mechanisms of curcumin including host-pathogen interaction and immunomodulatory effects, to explore the role of curcumin against COVID-19. With this background, our study suggests that curcumin can prevent COVID-19 infections by inhibiting the pathogen entry, viral genome replication and steps in the endosomal pathway along with inhibition of T-cell signalling by impairing the autophagy-mediated antigen-presenting pathway. This review explicit the possible mechanisms behind curcumin-induced cellular immunity and a therapeutive dosage of curcumin suggesting a preventive strategy against COVID-19.

curcumin can prevent COVID-19 infections by inhibiting the pathogen entry, viral genome replication and steps in the endosomal pathway along with inhibition of T-cell signalling by impairing the autophagy-mediated antigen-presenting pathway. This review explicit the possible mechanisms behind curcumin-induced cellular immunity and a therapeutive dosage of curcumin suggesting a preventive strategy against COVID-19.

COVID-19, Viral lifecycle, Curcumin, Immunomodulation, Prophylaxis, Therapeutic drug

Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione), also known as Diferuloylmethane, is a polyphenol product derived from the rhizomes of plant turmeric and other Curcuma sp. (Fig. 1) . Historically, curcumin, in the form of turmeric, is generally used for flavouring additives and food preservatives in Asiatic countries due to its anti-fungal and antioxidant property. The popular use of curcumin in research is mainly due to its pleiotropic properties including anti-inflammatory, anti-oxidant and anti-carcinogenic activities (Ahmad et al., 2020) . Curcumin can inhibit the inflammatory mediators, oxidation processes, and oxidative stress thereby acts as an anti-inflammatory agent against many diseases (Wal et al., 2019) . Praditya et al. (2019b) have shown curcumin as an anti-bacterial agent against several strains of Staphylococcus, Streptococcus, Helicobacter and Pseudomonas mainly by growth inhibition.

They also reported the anti-fungal property of curcumin. Different studies identified the efficacy of curcumin against Human immunodeficiency virus (HIV), Herpes simplex virus (HSV), the articles written in English, accessible full paper and relevance with the theme of the review, a total of 123 articles were finally selected for this comprehensive review.

The preliminary symptoms like cough and cold along with fever in COVID-19, gradually develop into further complications like severe pneumonia, coagulopathy and acute respiratory distress syndrome (ARDS). Accumulating information suggest that SARS-CoV-2 principally targets the cells which overexpress angiotensin-converting enzyme 2 (ACE2) and such target cells are airway epithelial cells, alveolar epithelial cells, vascular endothelial cells and macrophages in the lung. In general, men are more susceptible to COVID 19 and it has been linked with higher ACE2 expression in them compared to women (Jin et al., 2020; Sharma et al., 2020; Tay et al., 2020) . In addition to this, the risk of COVID 19 infections among children (Kelvin & Halperin, 2020) intrigued the need for host-pathogen interaction study in further detail.

The transmission of SARS-CoV-2 occurs via respiratory aerosols and binds to the nasal epithelial cells in the upper respiratory tract resulting in severe pneumonia-like symptoms.

Subsequent migration towards the lower respiratory tract causes damage in alveolar cells leading to the development of ARDS (Parasher, 2020) . Also, COVID-19-associated coagulopathy (CAC) presents many similarities with those of sepsis-induced coagulopathy (SIC)/disseminated intravascular coagulation (DIC), haemophagocytic syndrome (HPS)/haemophagocytic lymphohistiocytosis (HLH), antiphospholipid syndrome (APS), and thrombotic microangiopathy (TMA) . DIC like massive intravascular clot formation is frequently observed among severely ill COVID patients . Cytokine storm has been strongly associated with COVID-19 so far. Discharge of proinflammatory cytokines TGF β, etc.) and chemokines (CCL2, CCL3, CCL5, CXCL8, CXCL9, CXCL10, etc.) from immune effector cells lead to such lethal uncontrolled systemic inflammatory response . Although negligible changes in prothrombin time and platelet count were observed initially, unlike SIC/DIC, CAC displays increased D-dimer and fibrinogen levels.

Venous thromboembolism and arterial thrombosis are more frequent in CAC . Interestingly, secondary HLH is associated with COVID-19 disease severity and is characterized by the profound release of several cytokines and chemokines, including interleukin IL-2, IL-7, granulocyte-colony stimulating factor, interferon-γ inducible protein 10, monocyte chemo-attractant protein (MCP) 1, macrophage inflammatory protein (MIP) 1-α, and tumour necrosis factor (TNF)-α. Nonetheless, while neutrophil, monocyte, high-sensitivity C-reactive protein (Hs-CRP), procalcitonin were increased, the amount of eosinophil, lymphocyte numbers, lymphocyte-immune subsets, IgM, and C3 are found to be decreased significantly in COVID-19 patients Mehta et al., 2020) .

Several viral proteins encoded by the viral genome play a pivotal role in the viral lifecycle as well as immune evasion within the host cell (Astuti & Ysrafil, 2020; V'kovski et al., 2020) . Viral invasion impairs the innate immune system and thus are more prone to viral infection. The mechanism of viral replication and disease progression has been schematically shown (Fig 2) and highlighted the major viral proteins in Table 1 .

Like other viral infection, the lifecycle of SARS-CoV-2 involves four major steps i.e. viral entry by attachment and fusion into a host cell, endocytosis of the virus, genome expansion and virion release.

Attachment is the initial event that brings viruses to the cell membrane surface of the target cell through a receptor. Several studies have already established the importance of host cell receptors in viral infections, for example, hemagglutinin (HA) of Influenza virus binds with sialic acid (Samji, 2009) , Human Immune deficiency Virus (HIV) binds to CD4 receptor (Wilen et al., 2012) . Globally, a variety of studies have already confirmed that the S protein of the β-Coronavirus is a significant determinant of virus entry into host cells (Ou et al., 2020) . Previous studies have shown that envelope spike glycoprotein of SARS-CoV binds to CD209L (a C-type lectin) and angiotensin-converting enzyme 2 (ACE2) whereas MARS-CoV binds to Dipeptidyl peptidase 4 (DPP4, also known as CD26). Similar to SARS-CoV, SARS-CoV-2 also uses the angiotensin-converting enzyme 2 (ACE2) as a cellular receptor to penetrate the host system .

For an enveloped virus, delivery of the viral genome requires membrane fusion reaction between the lipid bilayer of the virus and a host target cell membrane (Doms, 2016) . In SARS-COV-2, this membrane fusion process is initiated by serine protease 2 (TMPRSS2) which activate the spike protein (S) through specific cleavage (Heurich et al., 2014; Hirano & Murakami, 2020; Hoffmann et al., 2020) . The binding of this spike protein to the receptor triggers the ADAM17mediated proteolytic "shedding" of ACE2 at the ectodomain site for the promotion of viral uptake into the cell (Ciaglia et al., 2020; Scialo et al., 2020) . Therefore, TMPRSS2 and ADAM17 both augment the viral entry into host cells and follow the clathrin-dependent and -independent endosomal pathway .

Following attachment and receptor clustering, many viruses are endocytosed and transported to endosomes where the low pH induces alterations in structural proteins of the virus that facilitate membrane fusion by protonating acidic residues. Generally, endocytic pathways include clathrin-mediated endocytosis, caveolae, macropinocytosis, and novel clathrin-and caveolae-independent pathways (Wang et al., 2008) . In the case of SARS-CoV-2, clathrin-mediated endocytosis occurs in nasal epithelial cells because of the abundance of GTPase, dynamin whereas clathrin-independent endocytosis occurs in pneumocytes. However, due to comparatively higher expression of C-terminal binding protein (CtBP) 1 & 2 and P21-activated kinase 1, macropinocytosis also occurs in pneumocytes (Glebov, 2020) . The virus-containing vacuoles undergo acidification, maturation and fusion with late endosomes or lysosomes. In the case of Influenza A virus, neuraminidase (NA) binds to lysosome-associate membrane proteins (LAMPs) and ruptures the membrane of the autophagosomes by deglycosylation (Ju et al., 2015) .

Likewise in SARS-CoV-2 infection, the ACE2-Spike protein complex is cleaved by cathepsin L protease within the autophagosomes leading to the fusion of viral and host cell membrane (Blaess et al., 2020) . The acidic environment initiates conformational modifications in the viral capsid resulting in exposure of hydrophobic domains within the endosomal membrane and forming a protein pore through which the viral genome can exit and enter the cytoplasm (Doms, 2016; Yamauchi & Helenius, 2013) . In this regards, nonstructural viral proteins like (NSP2, NSP3, NSP4 and NSP6) play a crucial role in virus escaping through pore formation in late endosome (discussed in Table 1 ).

The literature review suggests that RNA-dependent RNA polymerase (RdRp) plays an important role in the replication process of RNA viruses like SARS-CoV-2 (Mathew & Hsu, 2018) . After escaping from the autophagolysosome, genomic RNA undergoes an immediate translation. To avoid host detection, several non-structural proteins form a replication-transcription complex (RTC) as well as viral replication organelles like perinuclear double-membrane vesicles, convoluted membranes and small open double-membrane spherules (V'kovski et al., 2020) . Two overlapping open reading frame (ORF1a and ORF1b) translated into the viral enzymes 3C-like protease (3CLpro) and papain-like protease (PLpro), help in viral replication via proteolytic cleavage. Another segment of RNA encodes structural proteins of the virus, such as the spike (S), envelope (E), membrane (M) and nucleocapsid (N) proteins (Chen et al., 2020; Oyanguren et al., 2020; Shereen et al., 2020) . Translated structural proteins translocate into endoplasmic reticulum (ER) membranes and transport through the ER-to-Golgi intermediate compartment (ERGIC) . Freshly formed genomic RNA undergoes N-encapsidation, resulting in budding into the lumen of secretory vesicular compartments (V'kovski et al., 2020; .

Pathogen-associated molecular patterns (PAMPs) of the evolutionarily conserved microbes can be recognized by pattern recognition receptors (PRRs). Interestingly both

PRRs and then replicate in these vesicles, thereby avoiding the host detection of their dsRNA . In this regards, viral single-stranded RNA (ssRNA) and double-stranded RNA (dsRNA) are recognized by extracellular as well as endosomal Toll-like receptors (TLRs) and stimulate downstream signalling cascades (Vabret et al., 2020) . It has been found that TLR-7 plays a crucial role in SARS-CoV-2 genome recognition and clearance through exocytosis (Onofrio et al., 2020) . Also, an in-silico experiment reported that extracellular TLR-4 is most likely to be involved in recognizing molecular patterns from SARS-CoV-2 (Choudhury & Mukherjee, 2020).

However, the freshly formed envelope glycoproteins are inserted into the membrane of the endoplasmic reticulum or Golgi, and the Nucleocapsid is shaped by the combination of genomic RNA and Nucleocapsid protein. The virions germinate into the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) . Finally, the vesicles containing the virus particles fuse with the plasma membrane to release the virus through exocytosis and infect surrounding cells Shereen et al., 2020) .

A large group of scientists have tried to understand the immunological perspective of COVID-19. Usually soon after the virus enters into the host cell, the cellular immune response is initiated by PPRs recognition of PAMPs. This ligand binding activates several signalling pathways like NF-kB, IRF3 and AP-1 which synergistically stimulate IFN-1 production thereby limit virus entry as well as restrict viral replication (Taefehshokr et al., 2020) . In a healthy individual, a wellcoordinated immune response characterizes the first line of defence against viral infection, while on the contrary, extreme inflammatory innate response and dysregulated adaptive immune system ensue detrimental tissue damage at the systemic level (Catanzaro et al., 2020) . Although coronaviruses have a preferential tropism for lung cells, it mostly impairs the innate immune machinery by directly infecting T cells . SARS-CoV-2 targets multiple aspects of innate immunity like cytokine storm, impairing interferon signalling and suppression of antigen presentation on both MHC class I and II (Taefehshokr et al., 2020) . At the same time, an accumulation of mononuclear cells in the lungs coupled with a low level of hyperactive T-cells in the peripheral blood indicates that T-cells are attracted away from blood towards the infected sites to control the viral infection Tay et al., 2020) 

against SARS-CoV-2, are diagnosed in the blood around 7days after the onset of symptoms.

In the lung/alveolar epithelial cells, SARS-CoV-2 mainly deploy cellular immune responses and interfere with the IFN-signalling pathway with the membrane protein (M), Nucleocapsid protein (N) and non-structural proteins like NSP1, NSP3, PLpro acting as IFN antagonist (Taefehshokr et al., 2020; Tay et al., 2020) . During infection, non-structural proteins of this virus protect themselves from recognition by PRRs and inhibit the transcription of interferons leading to modulate IFN response in plasmacytoid dendritic cells (pDC) and other immune cells. This alters the cytokine secretion profile of infected cells to enhance the recruitment of myeloid immune cells over NK cells, which in turn produce more cytokines, creating a cycle of inflammation that damages the lung (Taefehshokr et al., 2020) . Apart from this interferon signalling, antigen presentation is an important antiviral mechanism that is being affected in the case of COVID-19.

In this regards, Macrophages in the lung and upper respiratory tract act as sentinel cells and are among the first immune cells to encounter incoming virion whereas DCs are key players in antigen presentation, cytokine production, instructing specific T cell responses Taefehshokr et al., 2020) . Nonetheless, coronaviruses trigger different complement pathways producing C3a and C5a components which then combine with dysregulated neutrophilia, endothelial injury and hyper-coagulopathy seem to be entangled to drive the severity of COVID-19 (Java et al., 2020; Liu & Ying, 2020) .

After an encounter with the infected cells, the viral antigen, through the endosomal crosspresentation pathway, will be presented to the antigen presentation cells (APC) and its antigenic peptides are accessible by major histocompatibility complex (MHC-I) or human leukocyte antigen (HLA) in humans thereby recognized by virus-specific cytotoxic T (CD8 + T) lymphocytes.

Antigen presentation subsequently stimulates the body's humoral and cellular immunity, which are mediated by virus-specific B and T cells . In the case of a healthy immune system, T cells become activated when CD8 + T cells recognize viral antigens by MHC-I molecules present on the infected cells. Then activated T cells undergo clonal expansion to proliferate into a large number of progeny T cells with identical receptors. This ultimately lyses the infected cells by inducing apoptosis and secrete pro-inflammatory cytokines (Gutierrez et al., 2020) . As a result, uncontrolled apoptosis of T lymphocytes occurs with the release of pro-inflammatory cytokines leads to local tissue damage and impairment of the immune system.

Chemistry of Curcumin

Curcumin is the main natural polyphenol found in turmeric (Curcuma longa) and other species of the Zingiberaceae family (Amalraj et al., 2017; Hewlings & Kalman, 2017) . The powdered extracts of turmeric-dried roots may contain essential oils, proteins, fat, minerals, carbohydrates, moisture, and curcuminoids (Ahmad et al., 2020; . The aroma of this spice is principally derived from sesquiterpenes which is a mixture of α-and β-turmerones with aromatic turmerone (Amalraj et al., 2017) . The polyphenols (curcuminoids) are a mixture of 71.5% curcumin, chemically a diferuloylmethane [1,7-bis(4-hydroxy-3-methoxy-phenyl)-hepta- (Amalraj et al., 2017; Hewlings & Kalman, 2017; .

Curcumin can be delivered by oral intake, subcutaneous, intraperitoneal, intravenous injection, topical and nasal treatment Nelson et al., 2017) . Later in phase II reaction, curcumin and its phase I metabolites are rapidly conjugated with glucuronic acid by UGTs (Uridine 5'-diphospho-glucuronosyltransferases) and

sulfate by SULTs (Sulfotransferases) at the phenol position (Dei Cas & Ghidoni, 2019).

Based on the above-explained mechanisms of infection pathogenesis, two major targets can be considered for the therapeutic approach -one is the lifecycle of the virus within the host cell and another part is the ability of the innate immune system to defend against infection.

Combating viral infection, viral entry and its replication within the host cell are the most important events and have always been a challenge. While non-enveloped viruses (e.g. have been conducted to explore the role of curcumin and its analogues on viral entry inhibition (Anggakusuma et al., 2014; Mathew & Hsu, 2018) . For instance, membrane fluidity experiments indicate that curcumin impairs both viral binding and fusion in the case of HCV and thus inhibit cell-to-cell transmission independent of the viral genotype (Anggakusuma et al., 2014) . Also, curcumin has a direct effect on viral particle infectivity redirected by the inhibition of haemagglutination in H1N1 as well as in H6N1 subtype and treatment with 30 μM curcumin reduced more than 90% virus yield (Praditya et al., 2019a) . Consistently, both the zika and chikungunya virus was responded to 5 µM curcumin without effecting the cellular viability. In a dose-and time-dependent manner, curcumin can reduce the infectivity of the enveloped viruses without disturbing the integrity of the viral RNA (Mounce et al., 2017) .

Recently literature revealed that curcumin holds the better binding capability to the ACE2 receptors and may hinder the entry of the COVID-19 virus (Zahedipour et al., 2020) . In-vivo studies revealed that curcumin derivatives at a comparatively low dose can decrease the level of Ang II thereby upregulate ACE2 protein (Pang et al., 2015; Xu et al., 2018) . Also, scientists have tried to explore the viral entry inhibition efficiency of curcumin using an insilico simulation study.

It has been found that curcumin can bind to the human ACE2 and receptor-binding domain of the viral S-protein with a binding energy of -7.8 Kcal/mol and -7.9 Kcal/mol respectively (Jena, 2019) .

Later, it has been found that keto and enol form of curcumin interacts (binding energy -20.753

Kcal/mol and -16.08067 Kcal/mol respectively) with the key residues (Q493, N501, Y505, Y489

and Q498) of the receptor-binding motif (RBM) in the spike glycoprotein (Shanmugarajan et al., 2020) . Also, curcumin may play important role in ADAM17 inhibition ( while HIV-1 integrase was inhibited at concentration IC 50 40 µM. In addition to this, curcumin also hinders transcription elongation by inhibiting the Tat protein of HIV-1 (Ali & Banerjea, 2016; Kumari et al., 2015; Prasad & Tyagi, 2015) . Recently an insilico analysis revealed that curcumin has a potential binding affinity with Ebola viral protein through which viral entry and replication might be inhibited (Noor et al., 2018) .

Recently some molecular docking studies reported that curcumin can possess an inhibitory effect on viral protein translation by binding with the active sites of 3CL Pro / chymotrypsin-like protease (NSP3) and PL Pro /papain-like protease (NSP5) (Das et al., 2020; Linda Laksmiani et al., 2020) .

Apart from targeting the viral lifecycle, the immune system plays an important role against infection. The role of curcumin as an immune-modulator against a plethora of viral and bacterial infection has been extensively studied (Lai et al., 2020; Mathew & Hsu, 2018; Sordillo & Helson, 2015) . Several mechanisms of cellular immunity against pathogen have been observed. This may lead to inhibit the suppressive activity of T-regulatory cells (Bhattacharyya et al., 2010) .

A more recent study revealed that curcumin can ease the grade of severity of ALI/ARDS and unrestrained inflammation by promoting the delineation of immature CD4 + T cells to CD4 + CD25 + FOXP3 + Treg (T-regulatory) cells (Chai et al., 2020).

inflammatory cytokines as a part of innate immunity activation to eliminate viruses. A large number of evidence suggest that curcumin potentially regulate cytokine release (Bereswill et al., 2010; Mathew & Hsu, 2018; Sordillo & Helson, 2015) . Curcumin inhibited the production of IL-8, MIP-1α, MCP-1, IL-1β, and TNF-α by PMA-or LPS-stimulated monocytes and alveolar macrophages in a concentration-and a time-dependent manner (Mathew & Hsu, 2018) while an integrated analysis revealed that five asymmetric mono-carbonyl analogues of curcumin can hinder the release of TNF-α and IL-6 in a dose-dependent pattern (Liang et al., 2014) . It has been shown that curcumin significantly increases the level of anti-inflammatory cytokine IL-10 and decrease pro-inflammatory cytokine expression in the mouse intestine (Bereswill et al., 2010) .

Another study found that IL-10 concentrations were significantly increased in curcumin-treated (average concentration of 200 mg/kg) hepatic cirrhosis mouse when compared to the non-treated group (Abo-Zaid et al., 2020) . Decreased serum level of TNF-α and IL-6 was also found in rat with acute renal injury after treatment of curcumin at a concentration of 100 µg/g body weight (Zhu et al., 2017) . A structure-activity relationship coupled with a molecular docking study showed that most of the curcumin derivatives effectively inhibit H1N1 neuraminidase activity.

Along with this, significant attenuation of pro-inflammatory cytokines (TNF-α, IL-6 and IFN-γ) levels was observed in mice after curcumin treatment (Lai et al., 2020) . Even so, a recent study on the mouse with an acute lung infection (ALI/ARDS) suggested that IL-17A, MPO-producing neutrophils decreased after pretreatment with 50 µL of curcumin at a concentration of 20 mg/mL (Chai et al., 2020) . Also, curcumin-stabilized silver nanoparticles (Cur-AgNP) significantly reduced HIV replication within the host cell by inhibition of pro-inflammatory cytokines level (Sharma et al., 2017) . However, a mouse model study revealed that curcumin potentially decreases the systematic as well as local myocardial expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) resulting in inhibition of NF-kB activation in Coxsackievirus infection (Song et al., 2013) . In contrast to this, a reduction of only local tissue inflammation was found in case of HSV-2 infection resulting decrease the risk of HIV acquisition in the female genital tract of women (Vitali et al., 2020) . Furthermore, Sordillo & Helson (2015) also showed a number of evidences regarding the action of curcumin against cytokine storm. They found that curcumin can effectively block the release of pro-inflammatory cytokines and thereby can be suggested as useful for treatment of Ebola patients.

induced activation of the alternate pathway of the complement system in a dose-dependent manner (Kulkarni, 2005) . In support of this, curcumin is also shown to decrease C3 activity with increase IgG and IgM, thereby trigger humoral immunity (Çiftçi, 2011) .

Since Fig. 2) .

While discussing the role of curcumin on COVID-19 treatment, insilico studies play important role in understanding the possible mechanism. Recently multi-omics based study has identified curcumin as a candidate prophylactic agent (Barh et al., 2020) . Curcumin possesses the binding efficiency to the RBD of the viral spike protein as well as human ACE2 causing the blockage of ACE2 receptor resulting in inhibition of the viral attachment with the host cell (Jena, 2019; Shanmugarajan et al., 2020) . Also, curcumin potentially binds to TMPRSS2 and ADAM17

leading to mispriming of the S-protein of the virus and hACE2 (Borah et al., 2016; Motohashi et al., 2020) . This possibly inhibits the membrane fusion process of viral entry into the lung/alveolar epithelial cells. In addition to this, curcumin can potentially increase soluble ACE2 protein which may competitively bind with SARS-CoV-2 not only to neutralize the virus but also rescue cellular ACE2 activity which negatively regulates the renin-angiotensin system (RAS) to protect the lung from injury . Not only entry inhibition, but curcumin can also impair the endosome-lysosomal fusion process by endosomal membrane stabilization (Marathe et al. 2012) and lysosomal membrane permeabilization (Chen et al., 2012) that eventually blocks the viral genome released into the host cell and prevent replication. Insilico simulation suggests the binding efficiency of curcumin with the NSP3 and NSP5 may affect the RdRP activity of viral genome replication and DMV formation (Astuti & Ysrafil, 2020; Das et al., 2020; Linda Laksmiani et al., 2020; Soni et al., 2020) . Also, impairment of the PLpro activity eventually protects the host cell environment by blocking NSP2 function and prevents the endosomal escape of essential nonstructural proteins (Astuti & Ysrafil, 2020; Yoshimoto, 2020) . Hence, it can be proposed that curcumin may inhibit several stages of the viral lifecycle within the host cell.

Earlier pieces of literature have already established the fact that curcumin acts as an immunomodulatory agent against viral infections and other inflammatory diseases. It was found that curcumin binds to a series of enzymes (carbonyl reductase, glutathione-S-transferase, glyoxalase, etc.) involved in reactive oxygen species (ROS) metabolic pathway and upregulate their expression (Larasati et al., 2018) . In oxidative stress condition, curcumin decreased malondialdehyde and nitric oxide levels by increasing thiol, superoxide dismutase, and catalase levels (Memarzia et al., 2021) . In the case of COVID-19, curcumin-induced inhibition of the autophagolysosome fusion may disturb MHC class-II antigen preparation and processing in the infected alveolar/lung epithelial cells. Thus, CD4 + T cells cannot be recognized by the APC (dendritic cell) thereby become unsuccessful to differentiate into T-helper cell. This inactivation of T cells is one of the primary mechanism behind the inhibition of pro-inflammatory cytokines release. Apart from this, curcumin interferes with TLRs leading to the NF-kB signalling pathway Liu & Ying, 2020) . This also activates IFN-1 signalling cascades that restricts viral genome replication and viral entry into the T cells. Overall, curcumin pro-inflammatory cytokine interleukin 4 (IL)-4, transforming growth factor-beta, IL-17, interferon-gamma levels, and type 1/type 2 helper cells (Th1)/(Th2) ratio in conditions with disturbance in the immune system (Memarzia et al., 2021) . Recently an integrated insilico simulation study revealed that hydrazinocurcumin act as a warrior against COVID-19 by altering the cytokine regulation (H. Noor et al., 2021) . The immunomodulatory role of curcumin against this infection understood so far, supports its potential prophylactic use, which either directly inactivates T-cell or regulate cytokine production.

The present review attempted to understand the molecular mechanism of COVID-19 pathogenesis.

A comparative analysis has been performed ( Table 2) considering several viral diseases and highlighted the dose-dependent response of curcumin in multiple test system (in vitro, in vivo and human population-based studies). It has been suggested that pre-treatment of curcumin may regulate lysosomal functions in a dose-dependent manner through ER/calcium/mitochondrial pathway . While most of the studies showed that curcumin can inhibit viral transcription when treated after exposure, some studies indicate that it can regulate cytokine release in case of pre-exposure treatment. However, a major criticism of curcumin has been raised regarding its poor bioavailability. Though dose-escalating studies have indicated the safety of curcumin at doses as high as 12 g/day over 3 months , curcumin possesses very poor bioavailability and often found in undetectable concentrations in blood and extra intestinal tissue due to its chemical instability, rapid metabolism, poor absorption and rapid systemic elimination (Dei Cas & Ghidoni, 2019; Lopresti, 2018; . Since most of the studies revealed the oral delivery of curcumin, it has been suggested that subcutaneous treatment of formulated curcumin provide effective and sustained tissue concentration ).

In addition to this, it has been found that different novel delivery systems such as solid lipid particle, micellar system, or hydrophilic nanoparticles could increase curcumin concentration up to 15-20 fold (Dei Cas & Ghidoni, 2019) .

Recent clinical trial showed that daily four times oral intake of 40mg nanocurcumin in micelles formation for 2 weeks can significantly decrease IL-6 and IL-1β expression and secretion in COVID-19 patients (Hassaniazad et al., 2020; Saber-Moghaddam et al., 2021; Valizadeh et al., 2020) . However, another trial of curcumin-piperine co-supplementation against COVID-19 is still being continued (Miryan et al., 2020) . Thimmulappa et al., (2021) suggested the nasal delivery of liposomal curcumin may inhibit SARS-CoV-2 infectivity by deposition of curcumin in the lower airways at a higher concentration and consequently mitigate pulmonary inflammation and the progression to ARDS. In summary, accumulated evidences suggested that curcumin can be effective against SARS-CoV-2 as supportive therapy. Table 2 provides a systemic representation of effective curcumin dose and hence can be utilized as a reference frame for validation in future.

While the entire world is putting efforts into the discovery of a vaccine against coronavirus infection, the antiviral potential of curcumin against SARS-CoV-2 shows a promising role in COVID-19 management. Since ancient time, curcumin possesses a multifaceted role in several disease management. As an antiviral agent, existing literature suggested that targeting viral lifecycle and cellular responses are important strategies to combat viral infection. The present review emphasized the molecular mechanism of host-pathogen interaction and subsequent immune response in the host. In this background, curcumin can potentially inhibit the SARS-CoV-2 entry within human mainly by blocking the ACE2 receptor, hinder viral genome replication by altering viral non-structural protein activity. Not only viral entry, curcumin indeed can prohibit 'cytokine storm'-induced multi-organ failure by constraining the inflammatory response and other cellular immune response. However, having such potency, it can be suggested that curcumin must be administered as solid lipid particle, micellar system, or hydrophilic nanoparticles due to its poor bioavailability. Hence, further studies warrant detailed dose-response analysis for validation in the large-scale human population.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

The authors declare that they have no conflict of interest. in the viral lifecycle and immune pathogenicity Table 2 The role of curcumin against viral disease management Table 3 The dose-dependent response of curcumin in multiple test system (in vitro, in vivo and population-based studies) Based on previous studies on antiviral potential or insilico prediction, Curcumin can be considered as both prophylactic as well as a therapeutic drug against COVID-19

The authors declare that they have no conflict of interest. Determine the shape of the virus envelope; helps to stabil nucleocapsids and promotes completion of viral assembly stabilizing N protein-RNA complex, inside the internal virio Structural protein

Composed of a serine-rich linker region between NTD and CTD NTD forms orthorhombic crystals and binds to the vi genome; linker region regulate self-functioning; CT promotes nucleocapsid formation; promotes the activation COX-2 leading to inflammation in the lungs; inhibits IFN causing restrictions in immune responses NSP1 (Leader protein) Inhibit host mRNA translation, antagonize IFN signalling a induce inflammatory cytokines and chemokines NSP2 Binding to prohibitin-1 (PHB1) and prohibitin-2 (PHB2) lea to disruption of the host cell environment Non-structural proteins NSP3 Encode papain-like protease (PLpro) that helps to cleave t site between NSP2 and NSP3 and release essential vi proteins for viral activity Proofreading of viral genome by endonuclease a methyltransferase activity NSP15 (Endoribonuclease) Cleaves RNA at 3'-uridylates to form a 2'-3' cyc phosphodiester product that protects viral RNA from h recognition and inhibit innate response NSP16 (2'-O-Ribosemethyltransferase)

Methylate 2'-hydroxyadenine using SAM as methyl po thereby avoid MDA5 recognition of viral RNA and inhi innate immunity regulation 

Immunomodulatory effect of curcumin on hepatic cirrhosis in experimental rats

Biochemistry, Safety, Pharmacological Activities, and Clinical Applications of Turmeric: A Mechanistic Review

Curcumin inhibits HIV-1 by promoting Tat protein degradation

Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives -A review

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells

Curcumin induced oxidative stress causes autophagy and apoptosis in bovine leucocytes transformed by Theileria annulata

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response

Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation

Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks

Impact of curcumin on toll-like receptors

COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children. Frontiers in Pediatrics

Curcumin prevents toxic effects of 2,3,7,8-tetrachlorodibenzo-p -dioxin (TCDD) on humoral immunity in rats

Autophagy and Its Role in MHC-Mediated Antigen Presentation

Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-κB pathways

An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study

Dietary Curcumin: Correlation between Bioavailability and Health Potential

Basic Concepts

The genetics of obesity: FTO leads the way

Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing

Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

Multitargeting by turmeric, the golden spice: From kitchen to clinic

Deciphering the TCR Repertoire to Solve the COVID-19 Mystery

The effect of

Turmeric on blood pressure modulation: A systematic review and meta-analysis

The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance 30 changes following treatment: A structured summary of a study protocol for a randomised controlled trial

TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2

Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein

Curcumin: A Review of Its Effects on Human Health

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Curcumin inhibits autophagy and apoptosis in hypoxia/reoxygenation-induced myocytes

The unique characteristics of COVID-19 coagulopathy

Coagulopathy in COVID-19

Recent Advances in Obesity: The Role of Turmeric Tuber and Its Metabolites in the Prophylaxis and Therapeutical Strategies

The complement system in COVID-19: friend and foe? JCI Insight

Catechin and Curcumin interact with corona ( 2019-nCoV / SARS-CoV2 ) viral S protein and ACE2 of human cell membrane : insights from Computational study and implication for intervention CURRENT STATUS : UNDER REVIEW

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in Public Health

Neuraminidase of Influenza A Virus Binds Lysosome-Associated Membrane Proteins Directly and Induces Lysosome Rupture

COVID-19 in children: the link in the transmission chain

Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection

Inhibition of HIV-1 by curcumin A, a novel curcumin analog. Drug Design

Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia

Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation

3D-quantitative structureactivity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase

Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth

Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study

Curcumin Inhibits Apoptosis of Chondrocytes through Activation ERK1/2 Signaling Pathways Induced Autophagy

Molecular immune pathogenesis and diagnosis of COVID-19

Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents. Drug Design, Development and Therapy

Active Compounds Activity from the Medicinal Plants Against SARS-CoV-2 using in Silico Assay

The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia

The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?

Differential Modulation of Intracellular Survival of Cytosolic and Vacuolar Pathogens by Curcumin

Antiviral potential of curcumin

The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections

COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet

Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of <scp> Curcuma longa </scp> and curcumin, an updated and comprehensive review

Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial

In Silico Study of Curcumin and Folic Acid as Potent Inhibitors of Human Transmembrane Protease Serine 2 in the Treatment of COVID-19

Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α

Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding

Curcumin induces crosstalk between autophagy and apoptosis mediated by calcium release from the endoplasmic reticulum, lysosomal destabilization and mitochondrial events

The Essential Medicinal Chemistry of Curcumin

Article in Pharmacognosy Research ·

Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 -a computational modeling

Toll-like receptors and COVID-19: a two-faced story with an exciting ending

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

The Emerging Role of Curcumin in the Modulation of TLR-4 Signaling Pathway: Focus on Neuroprotective and Anti-Rheumatic Properties

Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats. Drug Design

COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment

Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment

Anti-infective properties of the golden spice curcumin

Anti-infective Properties of the Golden Spice Curcumin

Curcumin, a component of golden spice: From bedside to bench and back

Curcumin and its analogues: a potential natural compound against HIV infection and AIDS. Food and Function

Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice

Curcumin, a Multifaceted Hormetic Agent, Mediates an Intricate Crosstalk between Mitochondrial Turnover

Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized <scp>coronavirus disease</scp> -19 patients: An open label nonrandomized clinical trial

Highlighting Curcumin-Induced Crosstalk between Autophagy and Apoptosis as Supported by Its Specific Subcellular Localization

Influenza A: understanding the viral life cycle

ACE2: The Major Cell Entry Receptor for SARS-CoV-2

Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets

Sex Differences in Mortality from COVID-19 Pandemic: Are Men Vulnerable and Women Protected? JACC: Case Reports

Immunomodulatory activities of curcumin-stabilized silver nanoparticles: Efficacy as an antiretroviral therapeutic

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Curcumin Protects Mice From Coxsackievirus B3-Induced Myocarditis by Inhibiting the Phosphatidylinositol 3 kinase/Akt/Nuclear Factor-κB Pathway

Curcumin, a traditional spice component, can hold the promise against COVID-19?

Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections

Covid-19: Perspectives on Innate Immune Evasion

The trinity of COVID-19: immunity, inflammation and intervention

Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19

Mechanisms of viral entry: sneaking in the front door

Coronavirus biology and replication: implications for SARS-CoV-2

Immunology of COVID-19: Current State of the Science

Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients

Curcumin can decrease tissue inflammation and the severity of HSV-2 infection in the female reproductive mucosa

A Detailed Insight of the Antiinflammatory Effects of Curcumin with the Assessment of Parameters, Sources of ROS and Associated Mechanisms

SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway

Autophagy Promotes Replication of Influenza A Virus In Vitro

RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion

Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation

HIV: Cell Binding and Entry. Cold Spring Harbor Perspectives in Medicine

Effects of a novel curcumin derivative on the functions of kidney in streptozotocin-induced type 2 diabetic rats

Virus entry at a glance

The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19

Potential effects of curcumin in the treatment of <scp>COVID</scp> -19 infection

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Curcumin targets the TFEB-lysosome pathway for induction of autophagy

Membrane heist: Coronavirus host membrane remodeling during replication

Curcumin inhibits apoptosis by modulating Bax/Bcl-2 expression and alleviates oxidative stress in testes of streptozotocin-induced diabetic rats

Curcumin protects against acute renal injury by suppressing JAK2/STAT3 pathway in severe acute pancreatitis in rats

Highlights Insilico study predicts that curcumin may potentially inhibit SARS-CoV-2 lifecycle within the host cell Curcumin may minimize tissue damage and vascular leakage by regulating cytokine storm Curcumin may protect cellular immunity by inhibiting autophagy-induced apoptosis, ROS generation, T-cell activation and trigger humoral immunity by affecting the complement system NSP4

The authors are thankful to Arijit Reeves, MSc student, Department of Environmental Science, University of Calcutta for helping in the VOSviewer analysis process and Ankita Das, Research scholar, Department of Environmental Science, University of Calcutta for putting necessary inputs to enrich the manuscript.